Background: APOE 4 and sex have been linked to increased risk for conversion to Alzheimer's disease (AD). However, the relationship between APOE 4 gene dose, sex, and AD biomarkers remains understudied. Objective: To investigate the effect of APOE 4 dose on AD biomarkers in a sample of older adults with mild cognitive impairment (MCI), and to examine whether APOE 4 dose modifies AD risk differently in MCI women and men. Methods: We examined cross-sectional AD biomarkers for participants with MCI (n = 930, 55-96 years old) from three large aging cohorts. Region of interest MRI volumes, global cognition, and episodic memory were analyzed by number of APOE 4 alleles and stratified by sex. Results: Across all participants, number of APOE 4 alleles was associated with smaller hippocampal and amygdala volumes and poorer cognition. When stratified by sex, women showed an APOE 4 dose effect for bilateral hippocampal and left amygdala volumes and cognition. In contrast, men showed an APOE 4 dose effect for hippocampal volumes with a trend in amygdala, but cognition did not differ between men with 1 and 2 APOE 4 alleles. Women with 2 APOE 4 alleles had poorer memory between 65-69 and poorer global cognition between 70-74 compared to men with 2 APOE 4 alleles. # Last authorship.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.